Abstract | New technologies have widened our view of 'complex diseases': those with both genetic and environmental risk factors. In this Review, we explore recent genetic and virological evidence implicating host-virus interactions in three diseases: type 1 diabetes, inflammatory bowel disease and asthma. The viruses implicated in these diseases cause mucosal infections that affect most of the population but are asymptomatic or mild in many hosts. These findings place a new emphasis on common viral infections as important environmental factors in the pathogenesis of complex diseases, and they compel the field to pursue a better understanding of host interactions with the human virome.
Mucosal surfaces provide portals of entry into the body not only for substances that are essential to survival, such as food, water, and air, but also for many pathogens, including viruses. To protect themselves, hosts have developed many antiviral immune mechanisms to combat these attacks. When a virus encounters a mucosal surface, the interplay between viral invasion and host antiviral defence strategies ultimately determines the severity and outcome of the infection.
Like all traits, the host antiviral response is dictated in part by genetics and can vary with genetic polymorphisms across the population. Similarly, other host proteins that are important for viral infection, such as cell surface receptors that are used by viruses, can vary across the host population. The significance of these vari ations may not be clear when studying the pathogenesis of a highly virulent virus in susceptible hosts. However, recent advances in viral detection are beginning to paint a new picture of mucosal viral infections in humans and other hosts: a picture in which viruses are frequently present, often in the absence of a clear-cut disease. In the context of frequent, less virulent infections, variations in the host antiviral response and in the host factors that are targeted by the virus may take centre stage in determining the physiological impact of a viral infection.
In this Review, we discuss how genetic and genomic technologies have widened our view of mucosal virus infec tions. In contrast to a 'one pathogen-one disease' model, we describe a model of the human virome in which people are almost continually exposed to viruses, which may or may not cause symptoms. In this context, the virome is an important component of the environment that can interact with host genetic traits to contribute to the pathogenesis of complex diseases. We highlight type 1 diabetes (T1D), inflammatory bowel disease (IBD) and asthma as examples in which interactions between host genetics and viral infections have been implicated in autoimmune and inflammatory diseases.
The expanding virome PCR and other genetic methods have revolutionized our ability to detect viruses in samples from infected hosts. Since the 1970s, viruses have been routinely detected in clinical and research laboratories using viral culture in combination with various antibody-based techniques 1 . Although these methods can be powerful, they are also labour intensive, can require multiple days for a result and can fail to detect many virus types. Since the invention of PCR 2 , nucleic acid-based techniques have been increasingly applied to the detection of viral genetic material within host fluids and tissues. In comparison to viral culture, a PCR-based test is fast, requiring only a few hours to complete, and is extremely sensitive. With the development of many reagents and platforms over the past decade, nucleic acid amplification techniques have become widely available and accessible; they are now the primary method for detecting viruses in research and are increasingly being adopted in clinical settings 3 . As one might expect, the introduction of sensitive, easily performed tests has led to a marked increase in virus detection in general, particularly in the setting of symptomatic illness. Classic epidemiological studies
Deep pyrosequencing
A technique for reading thousands to millions of short DNA sequences in parallel from a single sample.
Index case
The first person to get a disease. Often, this represents the first person in an epidemic or a chain of transmission for the disease.
Genome-wide association study
A study designed to identify genetic polymorphisms within a population that are associated with a disease phenotype.
of the 1950s and 1960s sought to identify agents of common respiratory and gastrointestinal infections. These studies were incredibly informative, but had low virus detection rates by modern standards. For example, the Tecumseh (Michigan, USA) study, which was carried out from 1965 to 1969, tested 1,419 secretions from individuals with symptomatic respiratory illnesses and isolated a pathogen from only one-quarter of the patients 4 . The most frequently detected agents in these studies, human rhinoviruses, were isolated in only 140 specimens (10%). By contrast, a study performed in 1998 using PCR found that 69% of tested adults with a cold carried detectable pathogens, the majority of which were rhinoviruses (in 50% of illnesses) 5 . Furthermore, in addition to improving the detection rate of known viruses, genetic methods have helped reveal previously unknown viral pathogens that underlie symptomatic illnesses. Several diseaseassociated viruses have been discovered in recent years using techniques such as PCR, viral gene arrays and, most recently, deep pyrosequencing [6] [7] [8] [9] , a technique that allows rare sequences to be detected. This powerful approach has been used to discover previously unidentified pathogens in patient samples, such as a novel picornavirus found in stool from patients with gastroenteritis 6, 10 . New genetic techniques have only just begun to be applied to pathogen discovery, but they hold great promise for further elucidating the members of the human virome.
In addition to improving detection of disease-causing viruses, genetic methods have highlighted the frequent presence of viruses in healthy individuals. For mucosal surfaces, this is exemplified by two groups within the family Picornaviridae: rhinoviruses and gastrointestinal enteroviruses. In cross-sectional studies using PCR, rhinoviruses were found to be prevalent in the respiratory tract. Detection rates in asymptomatic subjects average 15% across multiple studies, often with higher rates in young children 11 . Although rhinoviruses have always been considered prevalent, these rates are almost an order of magnitude higher than previous estimates. For example, in the Seattle (Washington, USA) Virus Watch (1965) (1966) (1967) (1968) (1969) , rhinoviruses were isolated from 2.3% of routine respiratory samples 12 . Similarly, recent PCRbased studies have extended the results of classic studies that used viral culture to show a significant prevalence of gastrointestinal enteroviruses in healthy children 13 . For example, two large recent studies detected enteroviruses in stool samples from 11% of asymptomatic infants 14, 15 ; further analysis showed that, in some individuals, the same enterovirus serotype could be detected in sequential stool samples for up to 4 months 16 . These initial observations may represent the 'tip of the iceberg' , as comprehensive surveys of mucosal viruses in asymptomatic subjects have not yet been carried out.
The significance of a positive PCR test in the absence of symptoms is a subject of current investigation. Longitudinal studies of respiratory viruses suggest that a positive test can be associated with an imminent or antecedent illness [17] [18] [19] . In addition, there is evidence that infections can begin, persist and terminate in the absence of symptoms. For example, in one study Winther et al. performed weekly nasal samplings in 15 children and documented eight examples of PCR-positive picornavirus infections that appeared, persisted for 2-3 weeks and disappeared without any symptoms 17 . Episodes of asymptomatic respiratory infection were also seen in a molecular epidemiology study in Finland that tracked family members of index cases (children who tested positive for a rhinovirus) with twice-weekly nasal sampling 20 . All siblings and half of the parents became PCR positive for 3 weeks for a rhinovirus during the study, but many of the parents had asymptomatic infections. Interestingly, family members sometimes became infected with the same strain as the index case, but many became positive for distinct strains, highlighting the great diversity of rhinoviruses circulating in a given season. These observations reveal that viruses often visit our mucosal surfaces 'under the radar' , without symptoms, and indicate that interactions between viruses and our antiviral immune system may be occurring even when we are unaware of an infection.
In the remainder of this Review, we discuss new evidence that common mucosal viral infections are important in the pathogenesis of complex disease. Even before the current age of gene-based pathogen detection, mucosal viral infections were known to be frequent. In the Cleveland (Ohio, USA) Family Study from 1948-1957, common respiratory illnesses were documented at an average of eight per year for children of 1-4 years of age, six per year for children of 5-9 years of age, five per year for children of 10-19 years of age and 3-4 per year for adults 21 . When surveyed by PCR, picornavirus infections alone can occur in the respiratory tract at rates as high as once per month in young children (on average, once every 2 months) 17 . If we consider symptomatic plus asymptomatic infections, a view emerges in which viruses are frequently, if not continuously, present at our mucosal surfaces. In our model, this constant (albeit changing) barrage of mucosal infections constitutes a virome that frequently interacts with host targets and host antiviral responses. This model emphasizes the potential importance of genetic polymorphisms in the host antiviral response in determining host health, including the susceptibility to complex disease.
In the digestive tract: diabetes and Crohn's disease For many years, investigators have sought infectious causes for autoimmune diseases such as T1D. Like infections, autoimmune diseases involve activation of the immune response and subsequent inflammation. However, no straightforward causal relationship between autoimmune diseases and particular pathogens has been uncovered. Recent evidence puts this search in a new context. Over the past few years, autoimmune diseases have been investigated extensively in genome-wide association studies (GWA studies). Researchers have used a variety of approaches to investigate how the genes identified in GWA studies relate to disease pathogenesis. For T1D and IBD, new evidence links disease development to regions of the host genome that are involved in host-virus interactions. Here, we present an overview of the relevant findings and refer readers to the cited references for more detailed information about the results these of studies.
Single-nucleotide polymorphism
A single nucleotide in the human genome sequence that differs from that found in other members of the population (or that found on the other allele in the same individual).
RIG-I-like receptor
One of a family of pattern recognition receptors, including RIG-I and MDA5, that can detect RNA associated with viral infection, such as the viral RNA genomes and viral replication intermediates.
Type I interferon
An interferon (IFN) that is produced and secreted in response to cellular stimuli associated with viral infection. Type I IFNs are important mediators of the innate antiviral immune response and include IFNα proteins and IFNβ proteins.
Interferon regulatory factor 7
A key transcription factor in the antiviral immune response pathway that transmits the signal from pattern recognition receptors to induce transcription of type I interferon genes.
Toll-like receptor
One of a family of pattern recognition receptors that recognize pathogen-associated molecular patterns, such as bacterial cell wall components or viral nucleic acids.
Type 1 diabetes. T1D is an autoimmune disease with genetic and environmental components. At its onset, usually during childhood, the host immune system attacks the insulin-producing β-cells of the pancreatic islets, leading to a lifelong dependence on exogenous insulin and many long-term health consequences. Although there is a tendency for the disease to be inherited in families, the concordance between identical twins is not 100% [22] [23] [24] [25] . Genetic loci linked to T1D have been identified through various methods, most recently through GWA studies.
Studies using GWA methods have confirmed some previously known T1D associations and revealed new ones, often involving immune function 26 . For example, the association was confirmed between T1D and polymorphisms in the human leukocyte antigen (HLA)-DR and HLA-DQ region on chromosome 6. This region encodes major histocompatibility complex (MHC) class II molecules, which present antigenic peptides to CD4 + T cells, and the association between this region and T1D fits with a large body of evidence indicating that adaptive immune responses contribute to T1D pathogenesis 27 . In 2006, a significant association was found between T1D and single-nucleotide polymorphisms (SNPs) in the gene that encodes MDA5 (also known as IFIH1) 28 , a cytoplasmic helicase that acts as an innate immune sensor of viral infection 29 . MDA5 is one of the RIG-I-like receptors (RLRs) that are expressed in the cytosol. On sensing viral RNA, activated MDA5 signals the cell to produce type I interferons (IFNs), initiating the antiviral immune response. Interestingly, MDA5 alleles that are present in the general population are associated with disease, whereas rare variants that result in a loss of function or reduced expression of the protein confer disease protection [30] [31] [32] . Consistent with these findings, a large population-based study showed that MDA5 is expressed at higher levels in leukocytes from individuals with T1D-susceptible alleles than in those with T1D-resistant alleles 33 , suggesting that there is a link between a robust antiviral immune response and T1D pathogenesis.
Recently, an innovative genomic analysis using data from GWA studies revealed a more extensive association between T1D and the antiviral immune response 34 . When interpreting GWA studies for complex diseases, a major limitation is often the low strength of the associations between individual polymorphisms and the disease state. To overcome this, the investigators looked for networks of genes that are co-regulated by transcription factors and then looked for associations between an identified gene network and GWA study data. This analysis used expression data from inbred rat strains to focus on a gene expression network driven by the immune system transcription factor interferon regulatory factor 7 (IRF7) 34 -a master regulator of the genes encoding type I IFNs 35 -and led to the discovery of a network of genes that are co-regulated by IRF7. In plasmacytoid dendritic cells, IRF7 is constitutively expressed and transmits the signal from the endosomal Toll-like receptor (TLR) proteins TLR7, TLR8 and TLR9 to the nucleus, to mediate transcription of type I IFN genes. In most other cell types, IRF7 expression is induced by signalling from the type I IFN receptor. By forming a homodimer, or a heterodimer with IRF3, IRF7 triggers transcription of type I IFN genes. Through these signalling pathways, innate recognition of viral nucleic acids by endosomal TLRs, cytosolic RLRs and DNA sensors results in the activation of type I IFN genes. Secreted IFNs, in turn, bind the type I IFN receptor and can induce the expression of ~300 IFN-stimulated genes, some of which have antiviral functions. Having identified a genomic locus that regulates the expression of the IRF7-driven network in rats -a locus that contains Epstein-Barr virusinduced gene 2 (Ebi2; also known as Gpr183) -the investigators sought to translate these findings to human disease by using human gene expression data from two large T1D GWA studies. A comparison of SNPs close to the genes in the IRF-driven network revealed a significant association with 'hits' from the T1D GWA studies. Furthermore, the genetic region containing the human orthologue of the rat locus that regulates expression of the IRF7 network, located at human chromosome 13q23, showed a significant association with T1D risk; SNPs associated with T1D were predicted to increase expression of the IRF7-driven network. These results demonstrate a link between T1D and an entire network of IFN response genes, extending well beyond MDA5 (FIG. 1) . But if the development of T1D involves the host antiviral response, which virus or viruses are inducing this response? Although many pathogens have been investigated, recent studies of T1D risk have focused on gastrointestinal entero viruses, such as coxsackievirus B (human enterovirus B) viruses. Various observations have implicated enteroviruses in T1D. In 1979, investigators isolated human coxsackievirus B4 from the pancreas of a diabetic child post-mortem. Inoculation of mice with this virus induced inflammation of pancreatic islets and death of β-cells 36 . Subsequently, other enteroviruses and related viruses were shown to induce diabetes in model hosts 37 . Epidemiological studies have also implicated entero viruses in T1D; in particular, recent longitudinal studies have shown that a positive PCR test for enteroviruses in the blood correlates with subsequent development of T1D in high-risk individuals [37] [38] [39] . Furthermore, enteroviruses detected in the islets of diabetic, but not control, pancreases in post-mortem exams and in vitro studies showed the tropism and destructive effects of enteroviruses on β-cells 37, 38 . One of the most intriguing clues implicating enteroviruses in T1D is the genetic evidence of a role for MDA5, as discussed above. MDA5 specifically senses members of the family Picornaviridae (which includes enteroviruses), whereas RIG-I (also known as DDX58) detects other virus families 40 . Despite these numerous associations, the role of enteroviruses in T1D pathogenesis has not yet been clearly defined.
Many pathogenic mechanisms are possible. In one scenario, infection of a β-cell by an enterovirus is followed by β-cell destruction -as a result of the virus itself, immune responses that kill virus-infected cells, or the 'autoimmune' sequelae of such an infection. Detailed discussions of possible mechanisms have been published 27, 37, 38, 41 . Whatever the mechanism, in this scenario the genotype of the host immune system is likely to be critical. In mouse models, a 'diabetogenic' picornavirus, the M variant of encephalomyocarditis virus, causes β-cell destruction and diabetes, but only in some genetic backgrounds 42, 43 . Also, enterovirus infections are quite common and usually do not lead to diabetes, suggesting the requirement for additional host (or viral) genetic factors. Moreover, in a typical infectious disease, the infectious agent is more pathogenic in the setting of a diminished immune response (such as immunosuppression). However, the genetic studies described above predict that a robust antiviral response correlates with the predisposition for T1D. This makes sense if the host immune response to the virus is more pathogenic than the virus itself. Consistent with this idea, mice IFIH1) is a cytosolic RLR that can recognize picornavirus genomes. Activated MDA5 activates the transcription factors IFN-regulatory factor 3 (IRF3) and nuclear factor-κB (NF-κB). By contrast, extrinsic recognition of viruses occurs through Toll-like receptor 3 (TLR3), TLR7, TLR8 and TLR9, which can recognize viral DNA and RNA within endosomes and activate transcription factors IRF7 and NF-κB. IRF3 and IRF7 function as homodimers or heterodimers to initiate transcription of type I interferons (IFNs) and other antiviral genes. Both pathways induce the expression of pro-inflammatory cytokines through NF-κB. Secreted type I IFNs bind to their receptor on the cell surface, and this receptor signals via STAT1 and STAT2 to induce expression of ~300 interferon-stimulated genes (ISGs), including MDA5 and IRF7. Type 1 diabetes (T1D) is linked to genetic polymorphisms in MDA5, IRF7 and an IRF7-driven network of ~300 genes (probably the depicted network of ISGs). Interestingly, T1D is predicted to correlate with robust responses through these pathways. For MDA5, polymorphisms that result in greater expression correlate with disease, whereas rare alleles that result in loss of or reduced function are protective. Similarly, as T1D-associated polymorphisms are present in the genomic locus that regulates the IRF7-driven network, it is possible that expression of this network is increased in T1D. dsRNA, double-stranded RNA; IBS1, IFNβ promoter stimulator 1 (also known as MAVS); ssRNA, single-stranded RNA.
that were genetically engineered to produce IFNα in β-cells develop islet inflammation and diabetes 44 . Thus, T1D may be a virus-induced disease in the setting of a detri mental host response dictated in part by genotype and in part by other environmental factors, such as the commensal microbiota 45 . Clearly, more investigation is required to delineate the role of viruses in T1D. At this time, however, we can state that converging evidence implicates a frequently encountered mucosal enterovirus infection as a key environmental factor in T1D pathogenesis.
Crohn's disease. As for T1D, genetic studies have offered many clues to the pathogenesis of Crohn's disease, a major subtype of IBD. Crohn's disease usually presents in young adults, with a second, smaller peak of onset in older adults, and involves transmural inflammation of the intestinal wall 46 . Inflammation usually occurs in the bacteria-dense distal ileum and colon, although multiple discontinuous regions of the intestine can be affected. Patients typically experience episodic symptoms, including fever, abdominal pain and diarrhoea, and may also experience more serious gastrointestinal problems. Risk factors for Crohn's disease can be either genetic or environ mental, with concordance rates of around 60% in monozygotic twins 47, 48 . In the late 1990s, genomewide studies revealed links between several chromosomal regions and Crohn's disease 49 . The first Crohn's disease gene identified in one of these regions was NOD2 (nucleotide-binding oligomerizing domain-containing protein 2), which encodes an innate immune receptor that recognizes components of the bacterial cell wall 50, 51 . Subsequently, genetic studies have implicated a number of genes in Crohn's disease, most of which have roles in immunological pathways or epithelial barrier functions 52, 53 . These findings fit with the current hypothesis that Crohn's disease pathogenesis involves disruption of the normal homeostatic interactions between the host and the bacterial microbiome of the intestine.
In addition, several studies have linked Crohn's disease to ATG16L1 and IRGM, which are involved in the autophagy pathway [54] [55] [56] [57] . Autophagy is an ancient cellular process that is important for removing unwanted debris from the cytosol, and it may affect Crohn's disease in a number of ways. During autophagy, a doublemembraned vesicle called the autophagosome surrounds cytosolic waste or, in some cases, pathogens. This autophagosome ultimately fuses with a lysosome, leading to digestion and recycling of the vesicle contents. In immune defence, autophagy can be important for both pathogen removal and pathogen recognition [58] [59] [60] . Recent studies of the autophagy protein ATG16L1 revealed that it has three distinct roles, all of which may be important in Crohn's disease. First, ATG16L1 can interact with the innate immune receptors NOD1 and NOD2 to mediate autophagy of bacteria 61, 62 . Second, ATG16L deficiency results in overproduction of the pro-inflammatory cytokine interleukin-1b in response to lipopolysaccharide 63 . Third, ATG16L1 appears to play a part in the biology of Paneth cells, which are specialized secretory cells that are located within the intestinal crypts and release antimicrobial compounds and other substances that affect the gut microbiota. In mice with reduced expression of ATG16L1 (ATG16L1 hypomorphs) 64 , Paneth cells display structural abnormalities in their secretory granules and an altered gene expression profile. This mouse model probably parallels human biology, as the histological abnormalities observed in mouse Paneth cells were also observed in intestinal biopsies from patients with Crohn's disease who carried the disease-associated allele of ATG16L1. Interestingly, further exploration of this Paneth cell phenotype uncovered an unexpected role for viruses in Crohn's disease pathogenesis: it was found that intestinal noroviruses are an essential ingredient for the abnormal Paneth cell phenotype of ATG16L1-hypomorphic mice 65 . Paneth cells of ATG16L1-hypomorphic mice reared in an enhanced-barrier facility (which provides an environment that prevents viral and bacterial infections) were indistinguishable from those of wild-type mice. The effect of murine norovirus had previously been detected in a conventional mouse facility 66 ; when this virus was tested with ATG16L1-hypomorphic mice reared in an enhanced-barrier facility, it was found that norovirus infection restored the abnormal Paneth cell phenotype. This result was dependent on the virus strain: a non-persisting norovirus strain did not induce the Paneth cell phenotype, whereas a persisting virus strain did. To further model Crohn's disease, mice were exposed to dextran sulphate sodium (DSS), a compound that causes intestinal injury and produces an IBD-like phenotype when ingested 67 . Virus-infected, but not uninfected, ATG16L1-hypomorphic mice displayed an abnormal response to intestinal injury, with pathology resembling that seen in humans with Crohn's disease (FIG. 2) . This phenotype was viral-strain specific and also required intestinal bacteria, as antibiotic treatment protected mice from the Crohn's disease-like pathology. The mechanism by which infection with noroviruses influences Paneth cells awaits further study; the ATG16L1 mutation did not result in increased viral titres and the virus was not detected within Paneth cells themselves. Nonetheless, these results provide a fascinating experimental demonstration of how a viral infection can profoundly influence the expression of a complex disease. It is noteworthy that intestinal noroviruses are common pathogens that have frequently been found in mouse colonies worldwide and are not symptomatic in wildtype hosts 66, 68, 69 . Thus, these results raise questions as to whether virus-host interactions are covertly influencing other disease phenotypes in model organisms raised in conventional facilities, and demonstrate the importance of searching for unrecognized effects that common viral infections may have on the pathogenesis of Crohn's disease and other complex human diseases.
In the respiratory tract: asthma Asthma is an important inflammatory disease of the lower airways. Although genetic and environmental risk factors have been defined, many mysteries remain about asthma pathogenesis. Worldwide, asthma affects approximately 300 million people, including >10% of the population in the United States and the United Kingdom 70 . The disease is usually characterized by asymptomatic periods punctuated with episodes of wheezing and respiratory distress ('exacerbations') accompanying acute lung inflammation. Long-term symptoms can include chronic inflammation and changes in lung structure and function. Asthma often occurs in association with allergies, and classic studies in both humans and animal models have demonstrated a role for allergic inflammation in asthma pathogenesis [71] [72] [73] . However, asthma is increasingly recognized as a heterogeneous disorder, because allergic mechanisms do not explain many of the findings in humans 74 . An intriguing development in asthma research has been the growing evidence linking asthma to respiratory viruses, especially human rhinoviruses. Inhaled allergens can trigger asthma exacerbations, and this phenomenon has been well studied in model organisms. However, longitudinal studies performed in the 1990s showed that 80-85% of exacerbations in patients with asthma are associated with respiratory infections 75, 76 . Multiple studies have confirmed these findings using PCR-based virus detection methods 77 . Although various respiratory infections have been associated with asthma exacerbations, human rhinoviruses are the most frequently detected pathogen, representing 60% or more of those identified [75] [76] [77] [78] [79] . Recent studies have suggested that the rhinovirus-asthma association may be even stronger; for example, using sensitive detection techniques, human rhinoviruses were detected in nearly 90% of children with severe asthma exacerbations 80 . Interestingly, the results of this and other studies suggest that the newly discovered human rhinovirus genogroup C may be particularly important in asthma, although additional studies are needed to clarify the roles of the different rhinovirus subtypes 81 . The epidemiology of childhood asthma further implicates rhinoviruses, as the timing of childhood asthma hospitalizations closely mirrors the timing of the annual rhinovirus epidemic, peaking dramatically 2 weeks after children return to school each year 82, 83 . In a recent study analysing cohorts of high-risk children (the Wisconsin (USA) Childhood Origins of Asthma (COAST) study) 84 , 259 children were analysed, starting from birth, for many asthma risk factors, including episodes of severe respiratory infection with wheezing. Children who had Crohn's disease requires both a genetic predisposition (a mutation in Atg16l1) and a viral infection for the manifestation of the disease phenotype. Paneth cells seem to be identical in ATG16L1-deficient hosts and wild-type hosts, and respond similarly to intestinal injury when norovirus infection is absent. However, whereas Paneth cells in wild-type hosts are not altered after a norovirus infection, ATG16L1-deficient hosts that are infected with a persistent strain of norovirus develop abnormal Paneth cells and have an abnormal response to intestinal injury, with histopathology resembling that seen in Crohn's disease. The injured colon in the ATG16L1-deficient mice contains lymphoid aggregates and shows abnormal thickening of the muscularis propria and inflammation of the submucosa. The Crohn's disease-like intestinal histopathology does not develop if these ATG16L1-deficient, virus-infected mice are treated with antibiotics, indicating that the intestinal microbiota is also an important environmental factor for the development of disease pathology.
Odds ratio
The ratio comparing the likelihood of an outcome (for example, a disease) between two groups (for example, cases and controls). It is measured as the ratio of the odds in one group to the odds in the other group and can be calculated as p (1 -q) / q(1 -p) , in which p is the probability of the event occurring for the first group and q, the probability for the second group.
Aeroallergen
An airborne allergen that can trigger an allergic reaction. Common aeroallergens are pollen and spores. a severe rhinovirus infection before the age of 3 years developed asthma by the age of 6 years in almost 90% of cases, representing an odds ratio of 25.6. By contrast, the odds ratio for developing asthma after early aeroallergen sensitization was only 3.4. In another recent cohort study, a positive association was found between early rhinovirus-mediated wheezing illness and subsequent development of asthma 85 . The mounting evidence for a rhinovirus-asthma association suggests that it is an important aspect of asthma pathogenesis.
Several studies have sought to determine whether subjects with asthma have an increased susceptibility to rhino virus infections. The Wisconsin COAST results raise three possibilities: individuals with asthma (or with the predisposition to asthma) have an enhanced susceptibility to rhinoviruses; rhinovirus infections affect the lung and contribute to the development of asthma; or both processes occur, possibly synergistically [86] [87] [88] .
A longitudinal study of domestic partners showed that individuals with asthma and those without the disease both encountered rhinoviruses at the same rate, but that those with asthma had prolonged and more severe symptoms of the infection 89 . In addition, experimental rhinovirus infections induce more lower-airway symptoms in subjects with asthma than in control subjects 90, 91 . Furthermore, ex vivo studies have demonstrated increased viral replication and decreased rhinovirus-induced IFN responses in airway epithelial cells from asthmatic subjects compared with levels in cells from control subjects [91] [92] [93] [94] , consistent with diminished IFN responses in patients with asthma in vivo 91, 95 . These results support the idea that patients with asthma have an altered response to rhinovirus infection, with more virus-induced pathology in the lower airway. However, these observations do not address whether this response is a consequence of the disease or part of the underlying cause. PCR-based studies have revealed a high incidence and prevalence of rhinovirus respiratory infections. At the same time, rhinoviruses have been identified as major precipitants of asthma exacerbations, and growing evidence indicates that subjects with asthma develop more severe symptoms on rhinovirus infection than healthy controls. Genetic polymorphisms that affect the host response to rhinoviruses could contribute to asthma pathogenesis. In this simplified scenario, all hosts experience frequent, repeated rhinovirus infections throughout their lifetimes (at least once every few months as children), and these infections may be asymptomatic, result in mild symptoms of the common cold or result in upper-and lower-airway inflammation with wheezing and respiratory distress. In normal hosts, rhinovirus infections affect only the upper airway and are mild or asymptomatic. Each infection fully resolves and leaves airways intact. In hosts who are predisposed to asthma, genetic polymorphisms in the antiviral immune response result in prolonged and more severe rhinovirus infections, with inflammation of both the upper and lower airways. In addition to these acute episodes, repeated severe infections lead to chronic inflammation and airway remodelling over time. This example illustrates how a common and frequent viral infection, in the setting of a detrimental host response, could contribute to the pathogenesis of asthma.
If patients with asthma have an abnormal response to rhinoviruses, it is likely that this aberrant host-virus interaction is central to asthma pathogenesis. Almost all children encounter rhinoviruses in early childhood, with seroconversion rates of 90% by the age of 2 years 96 .
As described above, childhood infections occur at least every few months, and new rhinovirus epidemics occur every year, probably owing to great virus diversity and continual emergence of new viral variants [97] [98] [99] . With this perpetual exposure to these viruses, it is easy to imagine how a deleterious response to rhinovirus infection could lead to acute and/or chronic lung injury (FIG. 3) . As many features of asthma manifest early in life 100 , sequelae of childhood infections could be particularly important. In the Crohn's disease model, it would be incorrect to consider norovirus infection the cause of this multifactorial disease, but it would also be incorrect to consider noroviruses as exacerbating factors in an established disease. Rather, noroviruses are essential contributors to disease pathogenesis, along with other genetic and environmental factors. Analogous to this, we propose that rhinovirus infections are fundamental for the induction of asthma, at least in many patients with this heterogeneous disease. In fact, it would be surprising if rhinovirus-host interactions did not contribute to asthma pathogenesis, if patients with asthma truly have an enhanced inflammatory response to this very common infection.
Thus far, observations in patients provide the main evidence for an abnormal response to rhinoviruses in individuals with asthma, but GWA studies of asthma have identified several associated genetic polymorphisms, many of which occur in immunological pathways that could affect host-virus interactions (such as polymorphisms in TLRs) 87, 101, 102 . Recent studies using knockdown by small interfering RNAs have implicated several innate immune pathways in host-rhinovirus interactions, including the TLR3 and RLR pathways 103, 104 . It will be interesting to see whether genetic polymorphisms that affect rhinovirus-triggered immune pathways influence host susceptibility to rhinoviruses or correlate with asthma. Another intriguing finding is the observation that severe rhinovirus-induced symptoms correlate, to some extent, with sensitization to aeroallergens 99, 105, 106 . One possibility is that infection of the lower respiratory tract by rhinoviruses promotes aeroallergen sensitization, or vice versa. However, an alternative explanation is that a common genetic polymorphism predisposes the host to both phenotypes. For example, a TLR polymorphism could bias the immune system towards allergic sensitization and also promote enhanced rhinovirus-induced inflammation 99 . Although many questions remain concerning asthma pathogenesis, a growing body of evidence indicates that host-virus interactions will play an important part in the pathology of asthma. Studies in model organisms have great potential to help elucidate the role of respiratory infections in asthma, such as a recent study showing an asthma-like phenotype in mice following viral infection 107 , in addition to genetic and clinical studies. The recent developments in asthma research illustrate how mainstream views of complex disease are being altered by a growing awareness of the role of mucosal viral infections.
Chronic infections and endogenous viruses
The human virome encompasses more than just frequent mucosal infections. Genetic techniques have demonstrated that the human population carries a high burden of chronic viral infections, many of which have unknown consequences (for a recent review, see REF. 108 ). Furthermore, genome sequencing has revealed multiple endogenous viruses in animal genomes, reflecting a historical record of those viral infections that have resulted in gene integration over time [109] [110] [111] . In humans, endogenous retroviruses constitute approximately 8% of the genome 109 . Interestingly, although most endogenous human viruses are defective, as they cannot reactivate to form complete viral particles, the viral genes contained in these sequences can be expressed 112 . This leaves open the questions of whether and to what extent endogenous viruses can activate the antiviral immune response or interact with host targets, as suggested by Variations in the antiviral response of the host may be important features of the pathogenesis of complex diseases. In this model, the population, consisting of non-susceptible and susceptible hosts, is exposed to highly prevalent viruses. Non-susceptible individuals with a normal, effective antiviral response do not develop the disease, whereas susceptible individuals are at risk of developing the disease if key environmental factors are present. An understanding of the immune system alterations that make individuals susceptible may allow for interventions the can render the individual insensitive to the environmental stimuli that induce disease, or that can alleviate or cure the disease after it has manifested. Such interventions might include vaccines, well-timed virus exposures or other immune-modulating therapeutics. This model suggests that it is critical to learn more about the human virome and the factors that influence host-virome interactions if we are to tackle complex diseases successfully. recent studies [113] [114] [115] . Recent findings about chronic infections and endogenous viruses further demonstrate how genetic and genomic techniques have expanded our knowledge of the human virome, focusing attention on how host variation in the antiviral immune response may influence complex disease pathogenesis.
The virome in homeostasis and disease Traditionally, viral infections of the mucosa have been seen as a deviation from host homeostasis, leading to disease and the subsequent resolution of that disease. However, emerging evidence suggests a different view, in which viral infections constitute a more constant feature of our environment. In contrast to studies of the human bacterial microbiome, few studies have examined the presence of mucosal viruses in healthy subjects using modern techniques. However, those studies that have been carried out have found that viral infections in the respiratory and gastrointestinal tracts are prevalent, although they may not result in symptoms. These results suggest a model in which mucosal infections are the norm rather than a deviation, and constitute a frequent (or even constant, albeit changing) virome. In this context, genetic variations in the viral factors that are targeted by hosts and in the host antiviral responses have the potential to dramatically affect host physiology, in some cases leading to complex disease (FIG. 4) . This model compels us to further investigate the nature and composition of the human mucosal virome and to identify the host proteins that interact with prevalent mucosal viruses. Although several projects have been proposed 116 , no study has yet characterized the virome of human pathogens in a comprehensive and systematic way. More detailed information about the human mucosal virome, particularly in healthy subjects, would be very relevant to the issues discussed here, and hopefully such studies will be pursued as technology advances.
A better understanding of the mechanisms by which host-virus interactions contribute to complex diseases might allow the development of new means of tackling these diseases. The prevalence of autoimmune and inflammatory diseases, such as those discussed here, is increasing in Western countries [117] [118] [119] . Understanding the role of the virome may help elucidate the reason for this epidemiological trend and indicate ways in which we can intervene. Furthermore, if we could identify an altered host-virus interaction that promotes the pathogenesis of a complex disease, it might be possible to design therapies to convert that interaction to the response of non-susceptible individuals, thereby protecting susceptible subjects (FIG. 4) . Future investigations of host-virome interactions hold great promise for providing new approaches to combating complex diseases.
